PLSE Pulse Biosciences, Inc.

44.41USD-3.10%Mkt Cap: 3.27B USDP/E: —

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutane…

Institutional holders20 on file

Key Statistics

Company
Market Cap3.27B USD
Enterprise Value3.19B USD
Revenue (TTM)1.49M USD
Gross Profit-189.00K USD
Net Income (TTM)-72.78M USD
Revenue/Share0.02 USD
Last Price44.41 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees116
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-38.37
PEG—
EV/EBITDA-36.84
EV/Revenue2133.81
P/S2186.28
P/B17.74
EPS (TTM)-1.21 USD
EPS (Forward)-1.16 USD
52W Range
12.5669% of range58.94
52W High58.94 USD
52W Low12.56 USD
Profitability
Gross Margin-54.00%
Oper. Margin-5861.24%
EBITDA Margin0.00%
Profit Margin-20794.57%
ROE-90.24%
ROA-76.99%
ROIC-815.75%
ROCE-88.83%
Growth
Revenue Growth359.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-54.12M USD
CapEx (TTM)335.00K USD
FCF Margin-2290.92%
FCF Yield-1.05%
Net Debt-182.83M USD
Net Debt/EBITDA2.11
Net Debt/FCF—
Balance Sheet
Debt/Equity0.09
Current Ratio14.35
Quick Ratio14.16
Book Value/Sh2.50 USD
Cash/Share2.57 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)67.67 USD
Upside (mean)+52.4%
Target Range60.00 USD – 74.00 USD
60.00+52.4% to mean74.00
# Analysts6
Ownership
Shares Out.73.55M
Float22.88M
Insiders68.90%
Institutions21.25%
Short Interest
Short Ratio7.2d
Short % Float12.44%
Short % Out.3.96%
Shares Short2.90M
Short (prev mo.)3.31M
Technical
SMA 5051.72 (-14.1%)
SMA 20033.51 (+32.5%)
Beta1.64
S&P 52W Chg12.08%
Avg Vol (30d)407.25K
Avg Vol (10d)467.03K
Technical Indicators
RSI (14)38.6
MACD-1.1583
MACD Signal0.1569
MACD Hist.-1.3152
BB Upper60.11 USD
BB Middle52.16 USD
BB Lower44.21 USD
BB Width30.50%
ATR (14)4.014 USD
Vol Ratio (20d)0.64x

About Pulse Biosciences (NASDAQ: PLSE)

›

Pulse Biosciences (NASDAQ: PLSE) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 116 employees.

The shares were at 44.41 USD on 19 November 2026, up 173.0% over 52 weeks. Its 52-week range is 12.56 USD to 58.94 USD: the price is 24.7% below the high and 253.6% above the low.

Its market capitalisation is 3.27B USD.

Pulse Biosciences reports return on equity of -90.2% and revenue up 359.3% year over year.

It holds more cash than debt, a net cash position of 182.83M USD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. 6 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 67.67 USD is 52.4% above the current price. The next earnings report is expected on 18 February 2027.